Examining Gender Differences in Social Media Language
Bulletin of Language and Literature Studies · 18.03.2025 · 2 (1)
DOI: 10.59652/blls.v2i1.519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Language and Literature Studies, online erschienen am 18.03.2025. Verfasst von Fatma Aydın. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study investigates how gender influences pragmatic language use across three major social media platforms: Twitter, Reddit, and WhatsApp. Drawing on a mixed-methods approach combining discourse analysis and frequency-based coding, the research examines the use of hedges, boosters, apologies, emojis, and mitigation strategies by male and female users. Results reveal that gendered communication patterns persist online but vary significantly by platform and context. Women used more affiliative and indirect forms, such as hedging and visual softeners, especially in private and semi-private conversations. Men showed greater reliance on directness and assertiveness, particularly in anonymous or debate-oriented environments. However, users of both genders demonstrated flexibility, shifting styles depending on audience and interactional goals. These findings contribute to current discussions on digital pragmatics, offering nuanced insights into how gendered identities are linguistically negotiated in technologically mediated settings.
Zitieren
APA
Aydın, F. (2025). Examining Gender Differences in Social Media Language. Bulletin of Language and Literature Studies, 2(1). https://doi.org/10.59652/blls.v2i1.519
Vancouver
Aydın F. Examining Gender Differences in Social Media Language. Bulletin of Language and Literature Studies. 2025;2(1). doi:10.59652/blls.v2i1.519
BibTeX
@article{Aydn2025,
author = {Aydın, Fatma},
title = {Examining Gender Differences in Social Media Language},
journal = {Bulletin of Language and Literature Studies},
year = {2025},
volume = {2},
number = {1},
doi = {10.59652/blls.v2i1.519}
}
EUVIMED